Delivery Order SPE2DB22D2006-SPE2DB25FW0PL
Award Date
5/5/25
Potential Completion Date
5/6/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,117.65 firm fixed-price contract is for the supply of VIMPAT 50 mg tablets. This order is under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA, valued up to $999,999,999 through December 2025, for providing a wide range of medical commodities to support military treatment programs and facilities worldwide. The...
This federal contract award, with ID SPE2DB24D1021|SPE2DB25FERVT, is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,311.11 firm fixed-price contract is for the supply of 4566338614 VIMPAT 200 MG TABLET 60S, with a period of performance through November 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,253.92 firm fixed-price delivery order is for the supply of VIMPAT 200 MG TABLET 60S, a specialty pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This single-award...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The order is for 60 tablets of the prescription drug VIMPAT 200 mg, with a firm fixed price of $2,314.38 and a completion date of April 19, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.28 firm fixed-price contract is for the delivery of Vimpat 200 mg tablets. It has an ultimate completion date of September 22, 2022. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award, valued at $1,192.45, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,567.64, is for the delivery of VIMPAT 10 MG/ML SOLUTION 200ML, a pharmaceutical product. The award is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of VIMPAT 50 MG TABLET 60S. The contract, with a ceiling value of $1,060.29, was awarded by the Defense Logistics Agency (DLA) on February 25, 2022 with a completion date of February 28, 2022. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running...
This contract award is for the delivery of VIMPAT 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA) by AmerisourceBergen Drug Corp's Corporate Office division. The contract has a ceiling value of $2,813.85 and is a Firm Fixed Price Delivery Order that runs through August 9, 2024. The award was made on August 8, 2024, and there is no set-aside designation. This contract is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,193.34 Firm Fixed Price Delivery Order is for the supply of 4,565,152,817 units of the pharmaceutical product VIMPAT 100 MG TABLET 60S, with an ultimate completion date of July 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...